Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1962 1
1963 1
1965 1
1966 1
1970 3
1971 2
1972 5
1973 4
1974 1
1975 7
1976 4
1977 2
1978 3
1979 1
1980 2
1981 3
1982 3
1983 1
1984 4
1985 1
1986 5
1987 7
1988 7
1989 6
1990 10
1991 13
1992 18
1993 8
1994 9
1995 4
1996 11
1997 18
1998 18
1999 26
2000 16
2001 9
2002 31
2003 19
2004 12
2005 23
2006 28
2007 36
2008 35
2009 43
2010 37
2011 54
2012 55
2013 66
2014 80
2015 76
2016 111
2017 133
2018 104
2019 112
2020 136
2021 168
2022 186
2023 63

Text availability

Article attribute

Article type

Publication date

Search Results

1,620 results

Results by year

Filters applied: . Clear all
Page 1
CCR7 as a therapeutic target in Cancer.
Salem A, Alotaibi M, Mroueh R, Basheer HA, Afarinkia K. Salem A, et al. Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188499. doi: 10.1016/j.bbcan.2020.188499. Epub 2020 Dec 29. Biochim Biophys Acta Rev Cancer. 2021. PMID: 33385485 Review.
Matrin3: Disorder and ALS Pathogenesis.
Salem A, Wilson CJ, Rutledge BS, Dilliott A, Farhan S, Choy WY, Duennwald ML. Salem A, et al. Front Mol Biosci. 2022 Jan 10;8:794646. doi: 10.3389/fmolb.2021.794646. eCollection 2021. Front Mol Biosci. 2022. PMID: 35083279 Free PMC article. Review.
Solubilized ubiquinol for preserving corneal function.
Naguib YW, Saha S, Skeie JM, Acri T, Ebeid K, Abdel-Rahman S, Kesh S, Schmidt GA, Nishimura DY, Banas JA, Zhu M, Greiner MA, Salem AK. Naguib YW, et al. Among authors: salem ak. Biomaterials. 2021 Aug;275:120842. doi: 10.1016/j.biomaterials.2021.120842. Epub 2021 May 1. Biomaterials. 2021. PMID: 34087583 Free PMC article.
Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies.
Liu L, Kshirsagar PG, Gautam SK, Gulati M, Wafa EI, Christiansen JC, White BM, Mallapragada SK, Wannemuehler MJ, Kumar S, Solheim JC, Batra SK, Salem AK, Narasimhan B, Jain M. Liu L, et al. Among authors: salem ak. Theranostics. 2022 Jan 1;12(3):1030-1060. doi: 10.7150/thno.64805. eCollection 2022. Theranostics. 2022. PMID: 35154473 Free PMC article. Review.
Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma.
Kaufman JL, Gasparetto C, Schjesvold FH, Moreau P, Touzeau C, Facon T, Boise LH, Jiang Y, Yang X, Dunbar F, Vishwamitra D, Unger S, Macartney T, Pesko J, Yu Y, Salem AH, Ross JA, Hong WJ, Maciag PC, Pauff JM, Kumar S. Kaufman JL, et al. Among authors: salem ah. Am J Hematol. 2021 Apr 1;96(4):418-427. doi: 10.1002/ajh.26083. Epub 2021 Jan 19. Am J Hematol. 2021. PMID: 33368455 Free PMC article. Clinical Trial.
Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma.
Costa LJ, Davies FE, Monohan GP, Kovacsovics T, Burwick N, Jakubowiak A, Kaufman JL, Hong WJ, Dail M, Salem AH, Yang X, Masud AA, Munasinghe W, Ross JA, Bueno OF, Kumar SK, Stadtmauer EA. Costa LJ, et al. Among authors: salem ah. Blood Adv. 2021 Oct 12;5(19):3748-3759. doi: 10.1182/bloodadvances.2020004146. Blood Adv. 2021. PMID: 34470049 Free PMC article. Clinical Trial.
Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study.
Karol SE, Alexander TB, Budhraja A, Pounds SB, Canavera K, Wang L, Wolf J, Klco JM, Mead PE, Das Gupta S, Kim SY, Salem AH, Palenski T, Lacayo NJ, Pui CH, Opferman JT, Rubnitz JE. Karol SE, et al. Among authors: salem ah. Lancet Oncol. 2020 Apr;21(4):551-560. doi: 10.1016/S1470-2045(20)30060-7. Epub 2020 Mar 11. Lancet Oncol. 2020. PMID: 32171069 Free PMC article. Clinical Trial.
Electrocardiogram Quiz.
Algarad A, Arabi A, Salem AM. Algarad A, et al. Among authors: salem am. Heart Views. 2022 Jul-Sep;23(3):157-159. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_217_20. Epub 2022 Oct 22. Heart Views. 2022. PMID: 36479177 Free PMC article. No abstract available.
Venetoclax exposure-efficacy and exposure-safety relationships in patients with treatment-naïve acute myeloid leukemia who are ineligible for intensive chemotherapy.
Brackman D, Eckert D, Menon R, Salem AH, Potluri J, Smith BD, Wei AH, Hayslip J, Miles D, Mensing S, Gopalakrishnan S, Zha J. Brackman D, et al. Among authors: salem ah. Hematol Oncol. 2022 Apr;40(2):269-279. doi: 10.1002/hon.2964. Epub 2022 Feb 9. Hematol Oncol. 2022. PMID: 35043428 Free PMC article. Clinical Trial.
1,620 results